This is the largest early-stage funding in China’s brain computer interface industry.

China could see brain-computer interface (BCI) technology move into practical public use within three to five years as ...

ReVision now anticipates initiating early-stage human clinical trials of its Occular BCI in blind volunteers in 2027.

Chinese brain-computer interface (BCI) startup, Gestala, has raised $21.6 million just two months after its launch, aiming to advance ultrasound-based BCI technology.

BrainWhisperer is Tether’s Brain-to-text project. Tether is earmarking resources to build technologies that push the borders of intracranial electrocortical decoding. The latest result is a variable ...

Science has added a whole lot more cash to the bank, bringing in an impressive $230 million in its latest raise. | Science has added a whole lot more cash to the bank, bringing in an impressive $230 ...

DelveInsight's Implanted Brain-Computer Interface Devices Market Insights report provides the current and forecast market ...

The growing adoption of BCI technology is attributable to its rising awareness in treating a wide range of brain disorders. The growing incidences of brain disorders, stroke, depression, and Parkinson ...

ReVision Implant announced today that it received FDA breakthrough device designation for its Occular visual cortical prosthesis.

BEIJING: China could see brain-computer interface (BCI) technology move into practical public use within three ...

Science’s brain computer interface (BCI) ecosystem is a neural data platform designed to simplify partners’ development of ...

The MarketWatch News Department was not involved in the creation of this content. Verified Market Research(R) a leading provider of business intelligence and market analysis is thrilled to announce ...